BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• GN Store Nord: Transactions in Relation to Share Buyback Program - Dec. 12, 2017

  The share buyback program has been initiated in order to reduce the company’s share capital and to cover obligations under the long-term incentive program.

  December 12, 2017

   · 

  1 min read
• Detecting Sleep Apnea: Leti Embeds Sensors in Wristband to Measure Heart Rate and Three Other Indicators

  APNEAband provides accurate, real-time detection of sleep-apnea events caused by pauses in breathing or shallow breaths during sleep.

  December 12, 2017

   · 

  3 min read
• Business

  Flexion Therapeutics Announces Appointment of Scott Kelley, M.D. as CMO

  Dr. Kelley will assumes responsibility for all medical matters at Flexion, including Medical Affairs, Clinical Research and Clinical Operations.

  December 12, 2017

   · 

  3 min read
• Biotech Bay

  Aduro Biotech to Host a Program Update Call

  The webcast will be archived and available for replay for one month following the event.

  December 12, 2017

   · 

  3 min read
• Genetown

  Acer Therapeutics Announces Proposed Underwritten Public Offering of Common Stock

  Acer intends to grant the underwriters a 30-day option to purchase an additional 15% of the shares of common stock offered in the public offering.

  December 12, 2017

   · 

  4 min read
• Business

  Almirall and Athenex Announce Strategic Partnership for the Treatment of Actinic Keratosis

  Athenex will grant to Almirall an exclusive license under the Athenex IP to research, develop and commercialize KX2-391 in the United States of America and European countries, including Russia.

  December 12, 2017

   · 

  9 min read
• Business

  Avinger Announces Change in Board Leadership

  John B. Simpson, PhD, MD, founder and Executive Chairman of Avinger, will be leaving the Company to pursue other opportunities.

  December 12, 2017

   · 

  3 min read
• Drug Development

  Actinium Pharmaceuticals Highlights Data at the American Society of Hematology Annual Meeting Showing CD33 Expression in a Significant Number of Multiple Myeloma Patients Supporting the Rationale for Actimab-M

  Actinium is the first and only company thus far to have a CD33 targeted therapy for multiple myeloma and the results from this analysis provide further rationale for the Company’s myeloma initiative.

  December 12, 2017

   · 

  5 min read
• Drug Development

  miRagen Therapeutics Presents New Interim Clinical Data Expanding on Previous Data Suggesting Positive Impact From Systemically Administered MRG-106 on Mycosis Fungoides Form of Cutaneous T-Cell Lymphoma

  The data are being presented at the 2017 American Society of Hematology (ASH) Annual Meeting in Atlanta, Georgia, by Christiane Querfeld, M.D., Ph.D., Chief of the Division of Dermatology, and Director, Cutaneous Lymphoma Program at the City of Hope in Duarte, California.

  December 12, 2017

   · 

  8 min read
• Business

  Peregrine Pharmaceuticals Reports Financial Results for Second Quarter of Fiscal Year 2018 and Recent Developments

  The company maintains its manufacturing revenue guidance for the full FY 2018 of $50 million - $55 million.

  December 12, 2017

   · 

  13 min read